2019 Innovations Reports for Cardiovascular Services
Innovations at a Glance
Originated the randomized multicenter ROMA trial aimed at evaluating the impact of the use of one internal thoracic artery versus two or more arterial grafts for coronary artery bypass graft.
Led a multicenter clinical trial finding that low-risk patients with severe aortic stenosis had a 46 percent lower risk of death, stroke, or rehospitalization when their aortic valve was replaced via TAVR versus open-heart surgery.
Developed a minimally invasive technique for transcarotid artery revascularization by directly accessing the carotid artery through a keyhole incision at the base of the neck.
Developing electromechanical wave imaging, a novel, non-invasive technology to better identify the origin of arrhythmias prior to cardiac ablation.
One of a handful of centers in the U.S. involved in a clinical trial to treat acute type A aortic dissections with the frozen elephant trunk graft technique.
Leading the international, multicenter RADIANCE-HTN SOLO and RADIANCE II trials to assess whether a device-based technique can reduce blood pressure.
Performed the first human case using the Conformal Left Atrial Appendage (LAA) Seal for LAA occlusion for the prevention of stroke in patients with atrial fibrillation.
Developed the AngioVac System, an endovascular suction device for filtering intravascular thrombi and emboli.
Offering the remedē® System, a newly FDA-approved phrenic nerve stimulation device for the treatment of central sleep apnea, a condition that can lead to heart failure and stroke.
Serving as sites for the NIH-sponsored CREST-2 trial assessing benefits of carotid stenting and endarterectomy versus intensive medical management to prevent stroke in patients with carotid stenosis who are asymptomatic.